#JACCCardioOnc #Tweetorial: Along the spectrum of cancer Tx, #YeSCCT has a lot to offer regarding identifying subclinical #ASCVD, excluding obstructive #cvCAD in cardiotoxicity when appropriate. #CardioOnc, as a field, can gain from incorporating CCT in practice.

🧵1/
#YeSCCT may identify subclinical #ASCVD in cancer patients & survivors. Reviewing previous non-gated thoracic CT scans for CAC may help identify subclinical #cvCAD and start prompt preventive Tx.

#JACCCardioOnc #CardioOnc #MedTwitter #CardioTwitter

2/
Several clinical scenarios in the context of cardiotoxicity may require ruling out obstructive #cvCAD. Cancer pts tend to have ⬆️ risk of complications from invasive procedures➡️ thrombocytopenia & hypercoagulable states. #YeSCCT may derive significant benefit. #JACCCardioOnc

3/ This table shows some possible clinical indications of #YeSC
Although #whyCMR has an established role in the assessment of cardiac masses, when not feasible #YeSCCT may be performed. This figure shows a pt case w/ #melanoma having episodes of VT. CCT was performed to assess for coronary anomaly or obstructive #cvCAD. #JACCCardioOnc

4/ An intramyocardial metastasis was identified, which was not
Thank you to the authors of this cardiac computed tomography study @BudoffMD, @onco_cardiology, @datsunian, @sdent_duke, @CardioOnc_MR_CT, @CardiacCTGuy.

Check out the article in #JACCCardioOnc: bit.ly/32eJYfK

#CardioOnc #CardioTwitter #YeSCCT #cvCAD #ASCVD

5/

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with JACC Journals

JACC Journals Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @JACCJournals

18 Nov 21
The new epidemic: ATTR Cardiac #Amyloidosis: Current and Emerging Treatment Strategies

Follow/share this #JACCCardioOnc #Tweetorial!

🧵 1/
ATTR cardiac #amyloidosis: Tip of the iceberg - current and emerging therapies to manage and prevent #heartfailure.

#JACCCardioOnc #CardioOnc

2/
ATTR #amyloidosis: Clinical progression and management strategies 👇

#JACCCardioOnc #CardioOnc

3/
Read 5 tweets
23 Apr 21
What are your pearls for assessing the mechanism & severity of #mitralregurgitation by #EchoFirst?

#JACCIMG presents an imaging-based curriculum to review functional #mitralvalve regurgitation for #CardioTwitter.

Follow/share this #Tweetorial! (1/15) bit.ly/3gw5MZ2
#JACCIMG Tweetorial Mitral regurgitation (2/15)

Case 1: What is the pathology shown?
JACCIMG #Tweetorial (3/15)

Shown is an example of flail leaflet of the #mitralvalve at the P2 segment.

Surgical #mitralvalve repair is the gold standard; due to prohibitive risk, the patient underwent successful percutaneous repair #TMVR, guided by 3D #EchoFirst.
Read 15 tweets
8 Apr 20
New #Coronavirus Research For #EPeeps (1/10):
While the use of hydroxychloroquine and azithromycin in patients with #COVID19 remains controversial, many patients receive this therapy. The primary adverse effect is QT prolongation and torsades de pointes/polymorphic VT. #JACCCEP
(2/10): A topical #COVID19 research letter published in #JACCCEP from investigators at @HeartsInRhythm in Vancouver explore the use of a handheld #ECG device versus a standard 12-lead ECG for QT monitoring. bit.ly/34joL10 Image
(3/10) The handheld #ECG would be ideal because it could minimize healthcare worker exposure. The study cohort included 22 patients referred to their center for a possible inherited arrhythmia syndrome. bit.ly/34joL10 #JACCCEP
Read 10 tweets
12 Oct 19
(1/12) #JACC #Tweetorial: #cvCAD in Young Adults: A Hard Lesson, but a Good Teacher
✔️#AFIJI Cohort 20 year-follow-up: fal.cn/34s2J @ActionCoeur
✔️ Editorial: fal.cn/34s2K by @ErinMichos and @AChoiHeart
@ActionCoeur @ErinMichos @AChoiHeart @MichelZedBay @mathieukerneis @docjohanne @DrHulot_PARCC (2/12) #JACC #Tweetorial: The consequences of premature #cvCAD are devastating. Declines in ASCVD events have not extended to younger adults and rates have increased particularly among women 35-54 yrs old.

Arora, et al @CircAHA: fal.cn/34s2N
@ActionCoeur @ErinMichos @AChoiHeart @MichelZedBay @mathieukerneis @docjohanne @DrHulot_PARCC @CircAHA (3/12) #JACC #Tweetorial: In this issue Collet, JP, et al (@ActionCoeur) describe a cohort of 880 adults who experienced symptomatic #cvCAD at a young age (<45 years) presenting as obstructive CAD followed for up to 20 years. fal.cn/34s3H
Read 12 tweets
11 May 19
(1/10) #JACC #Tweetorial: T2MI is #cvMI due to alterations in either myocardial oxygen supply and/or demand in the absence of acute atherothrombosis. It can occur in pts w/ normal coronaries and in obstructive/non-obstructive stable #cvCAD. fal.cn/AGvR
(2/10) #JACC #Tweetorial: Frequency of T2MI varies widely due to differences in populations, comorbidities, adjudication processes, & cTN assays, w/ a major challenge being the absence of uniform definitions that can be useful w/ high reproducibility. fal.cn/AGvR
(3/10) #JACC #Tweetorial: How T2MI manifests depends on the pathobiology & clinical context, w/ T2MIs less likely to have chest pain, imaging/#ECG abnormalities & ⬇ cardiac troponin concentrations compared to T1MI. Many T2MIs are driven by other illness. fal.cn/AGvR
Read 10 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(